The platelet-rich plasma market is growing, according to a new Global Industry Analysis report.
Here are 11 key trends:
1. Factors growing the PRP market include:
• Increased number of people suffering orthopedic injuries
• Growing PRP awareness
• New devices and applications for PRP
• Growing geriatric population
2. The pure PRP segment has the largest portion of the PRP market and held more than 60 percent market share globally in 2013.
3. The rich platelet content and growth factors are key factors contributing to the pure PRP segment.
4. Leukocyte-platelet rich fibrin is anticipated to be the fastest growing PRP segment from 2014 to 2020. The large number of stem cells and leukocytes and rapid injury factors are expected to boost this market segment growth.
5. The orthopedic surgery market was the largest application segment in 2013. It accounted for more than 30 percent of the global PRP market.
6. The orthopedic surgery market dominance is attributable to:
• Growing number of orthopedic and sports injuries
• Growing geriatric population
• High efficiency of PRP treating orthopedic injuries
7. The autologous PRP segment accounted for the largest global PRP market in 2013, but this segment is expected to anticipate losing market share through 2020 due to an increased emphasis on allogenic blood derived PRP products.
8. The allogenic PRP segment is expected to have the highest growth rate through 2020 because it reduces wound healing time and there is a high concentration of growth factors.
9. North America dominated the PRP market and held more than 50 percent of the market share. The factors driving growth include:
• Increased cosmetic and orthopedic procedures
• Key players domiciled in the region and strong awareness about PRP therapy
• Devices are supporting the dominance of the region.
10 Asia-Pacific is expected to witness strong growth and emerge as the most promising and fastest-growing market through 2020. The factors driving growth are:
• Medical tourism
• Wide presence of local players
• High geriatric population
• Growing PRP therapy awareness
11. The market is dominated by Harvest Technologies, Biomet, Arthrex, Arteriocyte Medical System. Other big players include Dr. PRP America, EmCyte, Regen Lab, Exactech and Cesca Therapeutics.